Azathioprine + Ustekinumab Aauz Interaction
Moderateinteraction on record
Description
Immunomodulator used concomitantly in approximately 30% of Crohn's disease and ulcerative colitis subjects. Use did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-aauz